AAAAAA

   
Results: 1-9 |
Results: 9
FENOLDOPAM, A SELECTIVE DOPAMINE-1 RECEPTOR AGONIST, RAISES INTRAOCULAR-PRESSURE IN MALES WITH NORMAL INTRAOCULAR-PRESSURE
Authors: PILTZ JR STONE RA BOIKE S EVERITT DE SHUSTERMAN NH AUDET P ZARIFFA N JORKASKY DK
Citation: Jr. Piltz et al., FENOLDOPAM, A SELECTIVE DOPAMINE-1 RECEPTOR AGONIST, RAISES INTRAOCULAR-PRESSURE IN MALES WITH NORMAL INTRAOCULAR-PRESSURE, Journal of ocular pharmacology and therapeutics, 14(3), 1998, pp. 203-216
CARVEDILOL UPDATE IV - PREVENTION OF OXIDATIVE STRESS, CARDIAC REMODELING AND PROGRESSION OF CONGESTIVE-HEART-FAILURE
Authors: FEUERSTEIN GZ SHUSTERMAN NH RUFFOLO RR
Citation: Gz. Feuerstein et al., CARVEDILOL UPDATE IV - PREVENTION OF OXIDATIVE STRESS, CARDIAC REMODELING AND PROGRESSION OF CONGESTIVE-HEART-FAILURE, Medicamentos de actualidad, 34, 1998, pp. 1-23
CARVEDILOL REDUCES CLINICAL PROGRESSION IN PATIENTS WITH MODERATE-SEVERE HEART-FAILURE
Authors: COLUCCI WS PACKER M BRISTOW MR FOWLER MB GILBERT EM COHN JN YOUNG ST SHUSTERMAN NH
Citation: Ws. Colucci et al., CARVEDILOL REDUCES CLINICAL PROGRESSION IN PATIENTS WITH MODERATE-SEVERE HEART-FAILURE, Journal of the American College of Cardiology, 29(2), 1997, pp. 7101-7101
RELATIONSHIP BETWEEN LONG-TERM CHANGES IN LEFT-VENTRICULAR FUNCTION AND CLINICAL OUTCOME IN PATIENTS WITH CHRONIC HEART-FAILURE TREATED WITH CARVEDILOL
Authors: PACKER M COLUCCI WS COHN JN BRISTOW MR FOWLER MB GILBERT EM HU JZ SHUSTERMAN NH
Citation: M. Packer et al., RELATIONSHIP BETWEEN LONG-TERM CHANGES IN LEFT-VENTRICULAR FUNCTION AND CLINICAL OUTCOME IN PATIENTS WITH CHRONIC HEART-FAILURE TREATED WITH CARVEDILOL, Journal of the American College of Cardiology, 29(2), 1997, pp. 7102-7102
CARVEDILOL UPDATE .4. PREVENTION OF OXIDATIVE STRESS, CARDIAC REMODELING AND PROGRESSION OF CONGESTIVE-HEART-FAILURE
Authors: FEUERSTEIN GZ SHUSTERMAN NH RUFFOLO RR
Citation: Gz. Feuerstein et al., CARVEDILOL UPDATE .4. PREVENTION OF OXIDATIVE STRESS, CARDIAC REMODELING AND PROGRESSION OF CONGESTIVE-HEART-FAILURE, Medicamentos de actualidad, 33(7), 1997, pp. 453-473
THE EFFECT OF CARVEDILOL ON MORBIDITY AND MORTALITY IN PATIENTS WITH CHRONIC HEART-FAILURE
Authors: PACKER M BRISTOW MR COHN JN COLUCCI WS FOWLER MB GILBERT EM SHUSTERMAN NH
Citation: M. Packer et al., THE EFFECT OF CARVEDILOL ON MORBIDITY AND MORTALITY IN PATIENTS WITH CHRONIC HEART-FAILURE, The New England journal of medicine, 334(21), 1996, pp. 1349-1355
DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF THE EFFECTS OF CARVEDILOL IN PATIENTS WITH MODERATE TO SEVERE HEART-FAILURE - THE PRECISE TRIAL
Authors: PACKER M COLUCCI WS SACKNERBERNSTEIN JD LIANG CS GOLDSCHER DA FREEMAN I KUKIN ML KINHAL V UDELSON JE KLAPHOLZ M GOTTLIEB SS PEARLE D CODY RJ GREGORY JJ KANTROWITZ NE LEJEMTEL TH YOUNG ST LUKAS MA SHUSTERMAN NH
Citation: M. Packer et al., DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF THE EFFECTS OF CARVEDILOL IN PATIENTS WITH MODERATE TO SEVERE HEART-FAILURE - THE PRECISE TRIAL, Circulation, 94(11), 1996, pp. 2793-2799
FENOLDOPAM, BUT NOT NITROPRUSSIDE, IMPROVES RENAL-FUNCTION IN SEVERELY HYPERTENSIVE PATIENTS WITH IMPAIRED RENAL-FUNCTION
Authors: SHUSTERMAN NH ELLIOTT WJ WHITE WB
Citation: Nh. Shusterman et al., FENOLDOPAM, BUT NOT NITROPRUSSIDE, IMPROVES RENAL-FUNCTION IN SEVERELY HYPERTENSIVE PATIENTS WITH IMPAIRED RENAL-FUNCTION, The American journal of medicine, 95(2), 1993, pp. 161-168
FENOLDOPAM, A SELECTIVE DOPAMINE-1 RECEPTOR AGONIST, RAISES INTRAOCULAR-PRESSURE IN MAN
Authors: PILTZ JR STONE RA AUDET P BOIKE S EVERITT D SHUSTERMAN NH JORKASKY D
Citation: Jr. Piltz et al., FENOLDOPAM, A SELECTIVE DOPAMINE-1 RECEPTOR AGONIST, RAISES INTRAOCULAR-PRESSURE IN MAN, Investigative ophthalmology & visual science, 33(4), 1992, pp. 1121-1121
Risultati: 1-9 |